Breaking News, Financial News

Financial Report: BASi

Returns to profitability in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BASi   3Q Revenues: $5.6 million (-22%) 3Q Earnings: $576,000 (loss of $246,000 3Q12) YTD Revenues: $16.6 million (-24%) YTD Earnings: $521,000 (loss of $3.6 million YTD13) Comments: Service revenue for the quarter was down 20% to $4.2 million, impacted by the consolidation of BASi’s Oregon lab into its West Lafayette facility. Product revenue decreased 27% to $1.4 million, primarily due to lower sales of Culex automated sampling systems. Earnings in the quarter are attributed to a hig...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters